These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
275 related articles for article (PubMed ID: 26561779)
41. The Intestinal Microbiome and the Liver Transplant Recipient: What We Know and What We Need to Know. Doycheva I; Leise MD; Watt KD Transplantation; 2016 Jan; 100(1):61-8. PubMed ID: 26647107 [TBL] [Abstract][Full Text] [Related]
42. The liver may act as a firewall mediating mutualism between the host and its gut commensal microbiota. Balmer ML; Slack E; de Gottardi A; Lawson MA; Hapfelmeier S; Miele L; Grieco A; Van Vlierberghe H; Fahrner R; Patuto N; Bernsmeier C; Ronchi F; Wyss M; Stroka D; Dickgreber N; Heim MH; McCoy KD; Macpherson AJ Sci Transl Med; 2014 May; 6(237):237ra66. PubMed ID: 24848256 [TBL] [Abstract][Full Text] [Related]
43. Microbiota and the gut-liver axis: bacterial translocation, inflammation and infection in cirrhosis. Giannelli V; Di Gregorio V; Iebba V; Giusto M; Schippa S; Merli M; Thalheimer U World J Gastroenterol; 2014 Dec; 20(45):16795-810. PubMed ID: 25492994 [TBL] [Abstract][Full Text] [Related]
45. Gut Microbiota-Derived Components and Metabolites in the Progression of Non-Alcoholic Fatty Liver Disease (NAFLD). Ji Y; Yin Y; Li Z; Zhang W Nutrients; 2019 Jul; 11(8):. PubMed ID: 31349604 [TBL] [Abstract][Full Text] [Related]
46. The intestinal microbiota and microenvironment in liver. Ma HD; Wang YH; Chang C; Gershwin ME; Lian ZX Autoimmun Rev; 2015 Mar; 14(3):183-91. PubMed ID: 25315744 [TBL] [Abstract][Full Text] [Related]
47. Intestinal Microbiota, Lipids, and the Pathogenesis of Intestinal Failure-Associated Liver Disease. Lee WS; Sokol RJ J Pediatr; 2015 Sep; 167(3):519-26. PubMed ID: 26130113 [No Abstract] [Full Text] [Related]
49. Gut microbiota and host metabolism in liver cirrhosis. Usami M; Miyoshi M; Yamashita H World J Gastroenterol; 2015 Nov; 21(41):11597-608. PubMed ID: 26556989 [TBL] [Abstract][Full Text] [Related]
50. The microbiome and regulation of mucosal immunity. McDermott AJ; Huffnagle GB Immunology; 2014 May; 142(1):24-31. PubMed ID: 24329495 [TBL] [Abstract][Full Text] [Related]
51. Antimicrobial proteins: intestinal guards to protect against liver disease. Hendrikx T; Schnabl B J Gastroenterol; 2019 Mar; 54(3):209-217. PubMed ID: 30392013 [TBL] [Abstract][Full Text] [Related]
52. Murine Fecal Microbiota Transplantation Alleviates Intestinal and Systemic Immune Responses in Heimesaat MM; Mrazek K; Bereswill S Front Immunol; 2019; 10():2272. PubMed ID: 31616437 [TBL] [Abstract][Full Text] [Related]
53. [Microflora of the upper part of the small intestine in diseases of the hepatobiliary system]. Knoke M; Bernhardt H Ter Arkh; 1980; 52(2):71-2. PubMed ID: 7376102 [No Abstract] [Full Text] [Related]
58. Effect of artesunate supplementation on bacterial translocation and dysbiosis of gut microbiota in rats with liver cirrhosis. Chen YX; Lai LN; Zhang HY; Bi YH; Meng L; Li XJ; Tian XX; Wang LM; Fan YM; Zhao ZF; Han DW; Ji C World J Gastroenterol; 2016 Mar; 22(10):2949-59. PubMed ID: 26973391 [TBL] [Abstract][Full Text] [Related]
59. Bacterial and eukaryotic extracellular vesicles and nonalcoholic fatty liver disease: new players in the gut-liver axis? Villard A; Boursier J; Andriantsitohaina R Am J Physiol Gastrointest Liver Physiol; 2021 Apr; 320(4):G485-G495. PubMed ID: 33471632 [TBL] [Abstract][Full Text] [Related]
60. Contribution of the Intestinal Microbiome and Gut Barrier to Hepatic Disorders. Chopyk DM; Grakoui A Gastroenterology; 2020 Sep; 159(3):849-863. PubMed ID: 32569766 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]